Monitoring menopausal symptoms in women with gynecological cancer after ovary removal
Official title: An Observational Study of Menopausal Symptom in Patients With Gynecological Malignancy After Oophorectomy (Carnation1)
Run by Anhui Provincial Hospital · NCT06151028 · Data updated 2026-11-12
This study looks at how menopause symptoms and bone health change over time in women aged 18-55 with gynecological cancer who have had their ovaries removed, to find the best ways to help them feel better and prevent bone loss.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 55 Years |
| Sex | Women only |
| Enrollment | 490 (estimated) |
| Sponsor | Anhui Provincial Hospital Government |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Hefei, Anhui) |
| Status | Recruiting |
| Started | December 1, 2023 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2033 |
| Registry record updated | March 7, 2024 |
| Trial ID | NCT06151028 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are premenopausal women aged 18-55 with specific gynecological malignancies who have undergone surgery involving bilateral ovariectomy.
✕Probably not a fit
Patients who are already postmenopausal or have other concurrent tumors may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on women aged 18-55 with gynecological malignancies who have undergone bilateral ovariectomy. It aims to monitor changes in menopausal symptoms and bone health over time, particularly the effects of platinum-based chemotherapy on these symptoms and bone loss. The study seeks to identify the optimal timing and effective regimens for menopausal hormone therapy in this unique patient population, providing guidance for osteoporosis screening and prevention strategies. By understanding these dynamics, the study aims to improve the quality of life for women facing early menopause due to cancer treatment.
Why it matters
Potential benefit: If successful, this study could lead to improved management of menopausal symptoms and bone health in women with gynecological cancers.
How similar studies have gone: While there is ongoing research in managing menopausal symptoms in cancer patients, this specific approach focusing on gynecological malignancies and early menopause is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Premenopausal women with gynecological malignancies aged 18-55 years old;
* Tumor types include endometrial cancer, cervical cancer, epithelial ovarian cancer;
* All patients received standard stage operation and treatment;
* Patients with bilateral ovaries resection; ⑤Voluntarily participate in this study, willing to sign informed consent, and have long-term follow-up conditions.
Exclusion Criteria:
* Menopause (women over 40 years of age stop menstruation for 12 months, excluding pregnancy and other diseases that may cause amenorrhea can be clinically diagnosed as menopause); Or AMH \< 0.2ng/ml (China Menopause Management and Menopause Hormone Therapy Guidelines 2023 edition); Or FSH\> 40 mIU/ml after two checks within one month;
* Other tumors were combined within 2 years and were still in radiotherapy, chemotherapy or hormone therapy;
* Diagnosis of immunodeficiency disease or active hepatitis B, C, active tuberculosis; ④Serious organic diseases of the organs, etc., can not cooperate with the study follow-up; ⑤Long-term use of hormonal drugs for rheumatic system diseases, such as glucocorticoids;
* Patients who have previously received pelvic or abdominal radiotherapy; ⑦ ECOG score ≥3 points; ⑧The patient did not sign informed consent or was unwilling to accept follow-up interviews.
Where it's running
-
Anhui Provincal Hospital
Hefei, Anhui, China Recruiting
Study contacts
- Study coordinator: Ying Zhou, MD
- Email: caddiezy@ustc.edu.cn
- Phone: +8613865901025
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Structured Combined Exercise Program for Postmenopausal Women
This trial tests whether a guided 12-week exercise program can improve heart health, menopausal symptoms, sleep, and quality of life in women aged 45–65 who are postmenopausal.
-
Menopause symptoms in Spanish women aged 40–70 and how activity affects them
This study will see if menopause-related symptoms are common among women aged 40 to 70 living in Spain and whether higher physical activity levels are linked to fewer or milder symptoms.
-
All-on-6 upper jaw implants placed with stackable guided surgery and immediate loading
This study will test whether a fully digital stackable guided surgery workflow with immediate loading works well for adults needing full-arch upper jaw (All-on-6) implants.
-
Guided Equator overdentures for the lower jaw
This project tests whether fully guided computer-assisted implant placement with Equator attachments gives reliable implant survival and less bone loss for adults with a completely edentulous lower jaw.
-
How three prosthetic methods affect bone levels around dental implants
This trial will test whether three different prosthetic approaches for posterior dental implants change marginal bone levels around the implant over one year in adults eligible for Lance implants.
-
Mandibular overdentures held by four Locator attachments versus a four-implant bar
This study tests whether mandibular overdentures retained by four Locator attachments or by a four-implant bar better preserve jaw bone in people who have been fully toothless for at least a year.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.